The outlook and analysis of Kodiak Sciences Inc. (KOD)’s stock

As of right now, Kodiak Sciences Inc. [KOD] is trading at $9.16, climbing up 6.26%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The KOD shares have lost -7.38% over the last week, with a monthly amount glided 12.39%, and seem to be holding up well over a long-time horizon.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


On 27, May 2022, Kodiak Sciences to Present at the Jefferies Global Healthcare Conference. In a post published today on Yahoo Finance, PALO ALTO, Calif., May 27, 2022 Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the Jefferies Global Healthcare Conference in New York, NY on Thursday, June 9, 2022, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time).

From an analyst’s perspective:

Kodiak Sciences Inc. [NASDAQ: KOD] stock has seen the most recent analyst activity on August 02, 2022, when Citigroup downgraded its rating to a Sell but kept the price target unchanged to $6 for it. Previously, JP Morgan downgraded its rating to Neutral on February 24, 2022, and dropped its price target to $21. On February 11, 2022, Goldman initiated with a Buy rating and assigned a price target of $70 on the stock. JP Morgan upgraded its rating to a Overweight and decreased its price target to $90 on February 02, 2022. ROTH Capital upgraded its rating to a Buy and reduced its price target to $149 on May 11, 2021. In a note dated March 01, 2021, Barclays downgraded an Underweight rating on this stock and boosted its target price from $52 to $90.

Through the last year, Kodiak Sciences Inc.’s stock price ranged from $4.90 to $131.97. Currently, Wall Street analysts expect the stock to reach $11.33 within the next 12 months. Kodiak Sciences Inc. [NASDAQ: KOD] shares were valued at $9.16 at the most recent close of the market. An investor can expect a potential return of 23.69% based on the average price forecast.

Analyzing the KOD fundamentals

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.73 points at the first support level, and at 8.31 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.44, and for the 2nd resistance point, it is at 9.73.

Kodiak Sciences Inc. [KOD] reported earnings per share of -$1.83 for its fiscal quarter that ended on 3/30/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$1.54/share, meaning a difference of $-0.29 and a surprise factor of -18.80%. By comparison, the stated earnings for the previous quarter ended on 12/30/2021 were -$1.79 per share as compared to estimates of -$1.36 per share, a difference of $-0.43 representing a surprise of -31.60%.

Ratios To Look Out For

It is important to note that Kodiak Sciences Inc. [NASDAQ:KOD] has a current ratio of 8.90. Further, the Quick Ratio stands at 11.36, while the Cash Ratio is 11.31.

Transactions by insiders

Insider trading, which has resulted in 46 insider purchases of 1,396,358 shares and 4 insider sales of 7,830 shares in the past three months, is now the topic of our analysis. Recent insider trading involved EHRLICH JASON, that happened on Jun 17 when 2282.0 shares were sold., BORGESON JOHN A. completed a deal on Jun 17 to sell 2798.0 shares. Meanwhile, BORGESON JOHN A. sold 1545.0 shares on Jun 15.